Browsing: Data

Clinical trials generate terabytes of imaging data—details on disease status, treatment effects, and progression—but biopharma sponsors don’t see most of…

Phase 1b results for GT-02287 point to biological impact in Parkinson’s, strengthening the case for disease-modifying approaches. Progress in Parkinson’s…

High angle view of a woman taking a nap in her bed at night. Researchers at Stanford Medicine have developed…

Credit: Svetlana Orusova / iStock / Getty Images Plus Earlier this month, Prime Medicine researchers hit a precision gene editing…

As Eli Lilly (NYSE: LLY) and Novo Nordisk (Nasdaq Copenhagen: NOVO-B) scramble to bring an oral glucagon-like peptide 1 (GLP-1)…

Researchers have traditionally employed histopathology techniques, which involve the microscopic examination of tissue, to gain insight into disease processes. This…

Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA) candidate clascoterone—both…

This project is massive, not just in scale, but in possibility. We’re talking about 50,000 hours of testing, a global…

The UK business, launched in 2023, has overcome a key barrier to uptake with the completion of its study comparing…

More than two weeks after Pfizer (NYSE: PFE) and Novo Nordisk (NASDAQ Copenhagen: NOVO-B) slugged it out for Metsera (NASDAQ:…